Table 4. Physiologic pathways over-represented by mRNA targets of the 11 CircaMiRs.
KEGG pathway | p-value | #genes | #miRNAs |
---|---|---|---|
Rap1 signaling pathway | 7.7E-05 | 30 | 9 |
Mucin type O-Glycan biosynthesis | 1.5E-03 | 4 | 4 |
Ras signaling pathway | 2.1E-03 | 30 | 8 |
Estrogen signaling pathway | 2.1E-03 | 14 | 7 |
Lysine degradation | 2.5E-03 | 6 | 6 |
ErbB signaling pathway | 3.3E-03 | 17 | 7 |
PI3K-Akt signaling pathway | 3.8E-03 | 38 | 9 |
Proteoglycans in cancer | 4.7E-03 | 23 | 7 |
Neurotrophin signaling pathway | 4.9E-03 | 19 | 7 |
Choline metabolism in cancer | 5.2E-03 | 15 | 8 |
Renal cell carcinoma | 1.2E-02 | 12 | 6 |
mTOR signaling pathway | 1.5E-02 | 11 | 6 |
Prolactin signaling pathway | 1.5E-02 | 11 | 7 |
MAPK signaling pathway | 1.5E-02 | 29 | 8 |
FoxO signaling pathway | 2.0E-02 | 17 | 7 |
Long-term potentiation | 2.5E-02 | 11 | 7 |
Endocytosis | 2.5E-02 | 21 | 8 |
Focal adhesion | 3.6E-02 | 23 | 8 |
Oocyte meiosis | 3.6E-02 | 14 | 7 |
Protein processing in endoplasmic reticulum | 4.6E-02 | 18 | 5 |
Insulin signaling pathway | 4.6E-02 | 17 | 5 |
Glutamatergic synapse | 5.0E-02 | 13 | 5 |